WO2023146536A1 - High yield extraction method for and products of rhodiola plants - Google Patents
High yield extraction method for and products of rhodiola plants Download PDFInfo
- Publication number
- WO2023146536A1 WO2023146536A1 PCT/US2022/014357 US2022014357W WO2023146536A1 WO 2023146536 A1 WO2023146536 A1 WO 2023146536A1 US 2022014357 W US2022014357 W US 2022014357W WO 2023146536 A1 WO2023146536 A1 WO 2023146536A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- solvent
- purified
- rhodiola
- mixture
- plant
- Prior art date
Links
- 241001165494 Rhodiola Species 0.000 title claims abstract description 47
- 238000000605 extraction Methods 0.000 title claims description 25
- 238000000034 method Methods 0.000 claims abstract description 72
- 239000002904 solvent Substances 0.000 claims abstract description 52
- 229930013930 alkaloid Natural products 0.000 claims abstract description 51
- 239000000203 mixture Substances 0.000 claims abstract description 50
- 241000196324 Embryophyta Species 0.000 claims abstract description 43
- 150000002989 phenols Chemical class 0.000 claims abstract description 17
- 239000007788 liquid Substances 0.000 claims abstract description 15
- RINHYCZCUGCZAJ-IPXOVKFZSA-N Rosavin Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)CO[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC\C=C\C=2C=CC=CC=2)O1 RINHYCZCUGCZAJ-IPXOVKFZSA-N 0.000 claims abstract description 11
- 230000008016 vaporization Effects 0.000 claims abstract description 10
- 238000001035 drying Methods 0.000 claims abstract description 9
- 238000001914 filtration Methods 0.000 claims abstract description 6
- 238000003306 harvesting Methods 0.000 claims abstract description 5
- 238000002156 mixing Methods 0.000 claims abstract description 5
- 238000005096 rolling process Methods 0.000 claims abstract description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 27
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 16
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 15
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 15
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 12
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 12
- 230000008569 process Effects 0.000 claims description 11
- 238000000926 separation method Methods 0.000 claims description 11
- 150000001875 compounds Chemical class 0.000 claims description 10
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 8
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 claims description 8
- QHMBSVQNZZTUGM-ZWKOTPCHSA-N cannabidiol Chemical compound OC1=CC(CCCCC)=CC(O)=C1[C@H]1[C@H](C(C)=C)CCC(C)=C1 QHMBSVQNZZTUGM-ZWKOTPCHSA-N 0.000 claims description 8
- 238000004587 chromatography analysis Methods 0.000 claims description 8
- 239000010460 hemp oil Substances 0.000 claims description 8
- 238000001704 evaporation Methods 0.000 claims description 7
- 230000008020 evaporation Effects 0.000 claims description 7
- 238000000746 purification Methods 0.000 claims description 6
- 238000002390 rotary evaporation Methods 0.000 claims description 6
- 238000004128 high performance liquid chromatography Methods 0.000 claims description 5
- -1 hydroalcohol Chemical compound 0.000 claims description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 5
- 244000198134 Agave sisalana Species 0.000 claims description 4
- 235000011624 Agave sisalana Nutrition 0.000 claims description 4
- 230000005526 G1 to G0 transition Effects 0.000 claims description 4
- QHMBSVQNZZTUGM-UHFFFAOYSA-N Trans-Cannabidiol Natural products OC1=CC(CCCCC)=CC(O)=C1C1C(C(C)=C)CCC(C)=C1 QHMBSVQNZZTUGM-UHFFFAOYSA-N 0.000 claims description 4
- ZTGXAWYVTLUPDT-UHFFFAOYSA-N cannabidiol Natural products OC1=CC(CCCCC)=CC(O)=C1C1C(C(C)=C)CC=C(C)C1 ZTGXAWYVTLUPDT-UHFFFAOYSA-N 0.000 claims description 4
- 229950011318 cannabidiol Drugs 0.000 claims description 4
- PCXRACLQFPRCBB-ZWKOTPCHSA-N dihydrocannabidiol Natural products OC1=CC(CCCCC)=CC(O)=C1[C@H]1[C@H](C(C)C)CCC(C)=C1 PCXRACLQFPRCBB-ZWKOTPCHSA-N 0.000 claims description 4
- 230000000391 smoking effect Effects 0.000 claims description 4
- 238000002485 combustion reaction Methods 0.000 claims description 3
- 238000004821 distillation Methods 0.000 claims description 3
- 238000004108 freeze drying Methods 0.000 claims description 3
- 230000003381 solubilizing effect Effects 0.000 claims description 3
- 238000001042 affinity chromatography Methods 0.000 claims description 2
- 238000004440 column chromatography Methods 0.000 claims description 2
- 238000004817 gas chromatography Methods 0.000 claims description 2
- 238000004191 hydrophobic interaction chromatography Methods 0.000 claims description 2
- 238000004255 ion exchange chromatography Methods 0.000 claims description 2
- 239000003446 ligand Substances 0.000 claims description 2
- 239000002808 molecular sieve Substances 0.000 claims description 2
- 238000004816 paper chromatography Methods 0.000 claims description 2
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 claims description 2
- 238000004809 thin layer chromatography Methods 0.000 claims description 2
- 235000002637 Nicotiana tabacum Nutrition 0.000 abstract description 2
- 241000208125 Nicotiana Species 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 21
- 244000042430 Rhodiola rosea Species 0.000 description 15
- 239000000047 product Substances 0.000 description 15
- YCCILVSKPBXVIP-UHFFFAOYSA-N 2-(4-hydroxyphenyl)ethanol Chemical compound OCCC1=CC=C(O)C=C1 YCCILVSKPBXVIP-UHFFFAOYSA-N 0.000 description 14
- 239000000284 extract Substances 0.000 description 13
- OOCCDEMITAIZTP-QPJJXVBHSA-N (E)-cinnamyl alcohol Chemical compound OC\C=C\C1=CC=CC=C1 OOCCDEMITAIZTP-QPJJXVBHSA-N 0.000 description 12
- 235000017807 phytochemicals Nutrition 0.000 description 11
- 229930000223 plant secondary metabolite Natural products 0.000 description 11
- 102000009132 CB1 Cannabinoid Receptor Human genes 0.000 description 7
- 108010073366 CB1 Cannabinoid Receptor Proteins 0.000 description 7
- DBLDQZASZZMNSL-QMMMGPOBSA-N L-tyrosinol Natural products OC[C@@H](N)CC1=CC=C(O)C=C1 DBLDQZASZZMNSL-QMMMGPOBSA-N 0.000 description 7
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 7
- 150000003797 alkaloid derivatives Chemical class 0.000 description 7
- 229930003827 cannabinoid Natural products 0.000 description 7
- 239000003557 cannabinoid Substances 0.000 description 7
- IEBFEMIXXHIISM-UHFFFAOYSA-N rozarin Natural products OC1C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OCC=CC=2C=CC=CC=2)O1 IEBFEMIXXHIISM-UHFFFAOYSA-N 0.000 description 7
- RINHYCZCUGCZAJ-UHFFFAOYSA-N rozavin Natural products OC1C(O)C(O)COC1OCC1C(O)C(O)C(O)C(OCC=CC=2C=CC=CC=2)O1 RINHYCZCUGCZAJ-UHFFFAOYSA-N 0.000 description 7
- 235000004330 tyrosol Nutrition 0.000 description 7
- RSWGJHLUYNHPMX-UHFFFAOYSA-N Abietic-Saeure Natural products C12CCC(C(C)C)=CC2=CCC2C1(C)CCCC2(C)C(O)=O RSWGJHLUYNHPMX-UHFFFAOYSA-N 0.000 description 6
- IEBFEMIXXHIISM-YZOUKVLTSA-N Rosarin Chemical compound O[C@@H]1[C@@H](O)[C@H](CO)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC\C=C\C=2C=CC=CC=2)O1 IEBFEMIXXHIISM-YZOUKVLTSA-N 0.000 description 6
- IEBFEMIXXHIISM-XZDFAHJYSA-N Rosarin Natural products O(C/C=C/c1ccccc1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO[C@H]2[C@@H](O)[C@@H](O)[C@@H](CO)O2)O1 IEBFEMIXXHIISM-XZDFAHJYSA-N 0.000 description 6
- KHPCPRHQVVSZAH-HUOMCSJISA-N Rosin Natural products O(C/C=C/c1ccccc1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 KHPCPRHQVVSZAH-HUOMCSJISA-N 0.000 description 6
- OOCCDEMITAIZTP-UHFFFAOYSA-N allylic benzylic alcohol Natural products OCC=CC1=CC=CC=C1 OOCCDEMITAIZTP-UHFFFAOYSA-N 0.000 description 6
- 230000008901 benefit Effects 0.000 description 6
- 229940065144 cannabinoids Drugs 0.000 description 6
- 238000003818 flash chromatography Methods 0.000 description 6
- 240000004308 marijuana Species 0.000 description 6
- KHPCPRHQVVSZAH-UHFFFAOYSA-N trans-cinnamyl beta-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OCC=CC1=CC=CC=C1 KHPCPRHQVVSZAH-UHFFFAOYSA-N 0.000 description 6
- 230000004048 modification Effects 0.000 description 5
- 238000012986 modification Methods 0.000 description 5
- 239000000419 plant extract Substances 0.000 description 5
- RBEAVAMWZAJWOI-MTOHEIAKSA-N (5as,6s,9r,9ar)-6-methyl-3-pentyl-9-prop-1-en-2-yl-7,8,9,9a-tetrahydro-5ah-dibenzofuran-1,6-diol Chemical compound C1=2C(O)=CC(CCCCC)=CC=2O[C@H]2[C@@H]1[C@H](C(C)=C)CC[C@]2(C)O RBEAVAMWZAJWOI-MTOHEIAKSA-N 0.000 description 4
- 150000001200 N-acyl ethanolamides Chemical class 0.000 description 4
- 235000003713 Rhodiola rosea Nutrition 0.000 description 4
- 239000002621 endocannabinoid Substances 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 208000019901 Anxiety disease Diseases 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- CYQFCXCEBYINGO-UHFFFAOYSA-N THC Natural products C1=C(C)CCC2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3C21 CYQFCXCEBYINGO-UHFFFAOYSA-N 0.000 description 3
- 230000036506 anxiety Effects 0.000 description 3
- 210000004556 brain Anatomy 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 238000010276 construction Methods 0.000 description 3
- 239000000287 crude extract Substances 0.000 description 3
- CYQFCXCEBYINGO-IAGOWNOFSA-N delta1-THC Chemical compound C1=C(C)CC[C@H]2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3[C@@H]21 CYQFCXCEBYINGO-IAGOWNOFSA-N 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 229960004242 dronabinol Drugs 0.000 description 3
- 150000003891 oxalate salts Chemical class 0.000 description 3
- 239000012071 phase Substances 0.000 description 3
- 230000003389 potentiating effect Effects 0.000 description 3
- 230000002195 synergetic effect Effects 0.000 description 3
- 206010006187 Breast cancer Diseases 0.000 description 2
- 208000026310 Breast neoplasm Diseases 0.000 description 2
- 102000009135 CB2 Cannabinoid Receptor Human genes 0.000 description 2
- 108010073376 CB2 Cannabinoid Receptor Proteins 0.000 description 2
- UVOLYTDXHDXWJU-UHFFFAOYSA-N Cannabichromene Chemical compound C1=CC(C)(CCC=C(C)C)OC2=CC(CCCCC)=CC(O)=C21 UVOLYTDXHDXWJU-UHFFFAOYSA-N 0.000 description 2
- VBGLYOIFKLUMQG-UHFFFAOYSA-N Cannabinol Chemical compound C1=C(C)C=C2C3=C(O)C=C(CCCCC)C=C3OC(C)(C)C2=C1 VBGLYOIFKLUMQG-UHFFFAOYSA-N 0.000 description 2
- 244000163122 Curcuma domestica Species 0.000 description 2
- 235000003392 Curcuma domestica Nutrition 0.000 description 2
- 244000136948 Ocimum sanctum Species 0.000 description 2
- 235000004072 Ocimum sanctum Nutrition 0.000 description 2
- 238000000944 Soxhlet extraction Methods 0.000 description 2
- 244000273928 Zingiber officinale Species 0.000 description 2
- 235000006886 Zingiber officinale Nutrition 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000012670 alkaline solution Substances 0.000 description 2
- QXACEHWTBCFNSA-SFQUDFHCSA-N cannabigerol Chemical compound CCCCCC1=CC(O)=C(C\C=C(/C)CCC=C(C)C)C(O)=C1 QXACEHWTBCFNSA-SFQUDFHCSA-N 0.000 description 2
- 235000003373 curcuma longa Nutrition 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000003480 eluent Substances 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 235000008397 ginger Nutrition 0.000 description 2
- 230000009931 harmful effect Effects 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 230000036651 mood Effects 0.000 description 2
- 235000006408 oxalic acid Nutrition 0.000 description 2
- 102000005962 receptors Human genes 0.000 description 2
- 108020003175 receptors Proteins 0.000 description 2
- 235000013976 turmeric Nutrition 0.000 description 2
- 238000009834 vaporization Methods 0.000 description 2
- 239000003981 vehicle Substances 0.000 description 2
- PBPYEEMQIFDGSQ-MOIFMYGASA-N (2R,3R,4S,5S,6R)-2-[(2E,4S)-4-hydroxy-3,7-dimethylocta-2,6-dienoxy]-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound CC(C)=CC[C@H](O)C(\C)=C\CO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O PBPYEEMQIFDGSQ-MOIFMYGASA-N 0.000 description 1
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 240000007124 Brassica oleracea Species 0.000 description 1
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 description 1
- 235000012905 Brassica oleracea var viridis Nutrition 0.000 description 1
- 241000218235 Cannabaceae Species 0.000 description 1
- 102000018208 Cannabinoid Receptor Human genes 0.000 description 1
- 108050007331 Cannabinoid receptor Proteins 0.000 description 1
- 102100033868 Cannabinoid receptor 1 Human genes 0.000 description 1
- 102100036214 Cannabinoid receptor 2 Human genes 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 208000030814 Eating disease Diseases 0.000 description 1
- 208000019454 Feeding and Eating disease Diseases 0.000 description 1
- 102000003688 G-Protein-Coupled Receptors Human genes 0.000 description 1
- 108090000045 G-Protein-Coupled Receptors Proteins 0.000 description 1
- 102000004310 Ion Channels Human genes 0.000 description 1
- 102000043136 MAP kinase family Human genes 0.000 description 1
- 108091054455 MAP kinase family Proteins 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 206010036618 Premenstrual syndrome Diseases 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- ILRCGYURZSFMEG-UHFFFAOYSA-N Salidroside Natural products OC1C(O)C(O)C(CO)OC1OCCC1=CC=C(O)C=C1 ILRCGYURZSFMEG-UHFFFAOYSA-N 0.000 description 1
- 102000019208 Serotonin Plasma Membrane Transport Proteins Human genes 0.000 description 1
- 108010012996 Serotonin Plasma Membrane Transport Proteins Proteins 0.000 description 1
- 244000300264 Spinacia oleracea Species 0.000 description 1
- 235000009337 Spinacia oleracea Nutrition 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 102000030621 adenylate cyclase Human genes 0.000 description 1
- 108060000200 adenylate cyclase Proteins 0.000 description 1
- 210000001789 adipocyte Anatomy 0.000 description 1
- 239000000556 agonist Substances 0.000 description 1
- 235000011114 ammonium hydroxide Nutrition 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 238000005842 biochemical reaction Methods 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- QXDMQSPYEZFLGF-UHFFFAOYSA-L calcium oxalate Chemical compound [Ca+2].[O-]C(=O)C([O-])=O QXDMQSPYEZFLGF-UHFFFAOYSA-L 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 239000002894 chemical waste Substances 0.000 description 1
- 238000011210 chromatographic step Methods 0.000 description 1
- 230000019771 cognition Effects 0.000 description 1
- 230000003920 cognitive function Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 244000038559 crop plants Species 0.000 description 1
- 230000001351 cycling effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 235000014632 disordered eating Nutrition 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 230000002996 emotional effect Effects 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000001508 eye Anatomy 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 210000003405 ileum Anatomy 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 210000005171 mammalian brain Anatomy 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 239000000401 methanolic extract Substances 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000020477 pH reduction Effects 0.000 description 1
- 230000008447 perception Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000003518 presynaptic effect Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 208000020016 psychiatric disease Diseases 0.000 description 1
- 239000003642 reactive oxygen metabolite Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- JJYVNURTNGHITH-UHFFFAOYSA-N rosavin Natural products OC1COC(OCC2OC(OC(=O)C=Cc3ccccc3)C(O)C(O)C2O)C(O)C1O JJYVNURTNGHITH-UHFFFAOYSA-N 0.000 description 1
- PBPYEEMQIFDGSQ-YTQIUSBHSA-N rosiridin Natural products CC(=CC[C@@H](O)C(=CCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)C)C PBPYEEMQIFDGSQ-YTQIUSBHSA-N 0.000 description 1
- ILRCGYURZSFMEG-RQICVUQASA-N salidroside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)OC1OCCC1=CC=C(O)C=C1 ILRCGYURZSFMEG-RQICVUQASA-N 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 229930000044 secondary metabolite Natural products 0.000 description 1
- 230000013275 serotonin uptake Effects 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000011877 solvent mixture Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 235000011149 sulphuric acid Nutrition 0.000 description 1
- 230000003319 supportive effect Effects 0.000 description 1
- 210000001550 testis Anatomy 0.000 description 1
- 238000000825 ultraviolet detection Methods 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 239000006200 vaporizer Substances 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/18—Treatment of tobacco products or tobacco substitutes
- A24B15/24—Treatment of tobacco products or tobacco substitutes by extraction; Tobacco extracts
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/10—Chemical features of tobacco products or tobacco substitutes
- A24B15/16—Chemical features of tobacco products or tobacco substitutes of tobacco substitutes
- A24B15/167—Chemical features of tobacco products or tobacco substitutes of tobacco substitutes in liquid or vaporisable form, e.g. liquid compositions for electronic cigarettes
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/18—Treatment of tobacco products or tobacco substitutes
- A24B15/24—Treatment of tobacco products or tobacco substitutes by extraction; Tobacco extracts
- A24B15/26—Use of organic solvents for extraction
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/18—Treatment of tobacco products or tobacco substitutes
- A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
- A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
- A24B15/302—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances by natural substances obtained from animals or plants
- A24B15/303—Plant extracts other than tobacco
Definitions
- the present invention relates to methods of high yield extraction of herbaceous plant matter. More particularly, the present invention relates to methods of high yield extraction of Rhodiola Rosea plant species, and products thereof, for medicinal and commercial use.
- Rhodiola an herbaceous plant, is indigenous to various parts of Northern China and Russia. There are at least three species of Rhodiola, of which, consuming of Rhodiola Rosea is preferred.
- Crude plant extracts or plant material traditionally consumed by ingestion contains many compounds, such as secondary metabolites, which may affect many targets in the body simultaneously.
- These complex mixtures of phytochemicals may have numerous, synergistic effects in the body and “minor” metabolites may likely affect targets that have an equilibrizing effect that can, for example, mitigate side effects as compared to a synthetic pure pharmaceutical.
- the overall effect may be more desirable and more potent than that of only one compound alone.
- Rhodiola e.g., Rhodiola Rosea
- Rhodiola Rosea e.g., Rhodiola Rosea
- salidrosides rosavins
- tyrosol tyrosol
- roasarin rosin
- rosin rosin
- cinnamyl alcohol a consumable concentration of 5% salidrosides and 3% rosavins is considered to be optimized for action as an agonist on the cannabinoid receptors for use with cannabis (and other herbs).
- Endocannabinoids act as retrograde signaling messengers that stimulate presynaptic CB1 receptors on neurons in the brain. This stimulation results in regulation of ion channel activities, inhibition of adenylate cyclase activity and activation of the mitogen- activated protein kinase cascade.
- CB1 receptors are the most abundant receptors in the mammalian brain, and also have been detected in other peripheral tissues and cells such as testis, eye, urinary bladder, ileum and adipocytes, though in lower concentrations than in the brain. CB1 receptors are found in brain areas related to the control of anxiety and emotional perception. In rats, CB1 receptors have been found with 5-HT transporters in the amygdale, suggesting that they mediate 5-HT release therefore possibly a target for the treatment of disorders related to mood, anxiety and cognition.
- Rhodiola species i.e. Rhodiola Rosea
- Rhodiola Rosea have been shown to display potent CB1 receptor binding.
- the mood enhancing and stimulant properties of the whole plant extract of Rhodiola Rosea has been traditionally utilized for therapeutic purposes in Russia, Scandinavia, and China .
- preparations of R. Rosea have shown it can improve cognitive function and memory.
- a method of extracting a Rhodiola plant which includes the steps of harvesting and drying the Rhodiola plant; extracting the alkaloids from the Rhodiola plant in a solvent; filtering the solvent-Rhodiola plant mixture to remove the solvent and extracted alkaloids from a spent Rhodiola plant matter; drying the spent Rhodiola plant matter; purifying and separating the extracted alkaloids from the solvent; and mixing the purified alkaloids back into the dried spent Rhodiola plant matter.
- a vaporizing liquid having a mixture of the purified alkaloids and the dried spent Rhodiola plant matter produced according to the method of extraction. Further provided is a vaporizing liquid wherein the extraction method further has a step of solubilizing in a second solvent.
- a medicinal composition having a mixture of the purified alkaloids and dried spent Rhodiola plant matter produced according to the method of extraction.
- a kief composition having a mixture of the purified alkaloids and dried spent Rhodiola plant matter produced according to the method of extraction.
- Rhodiola plant having a total phenolic compound content of 1 .3-8.57% containing 1-3.5% salidrosides and 0.03-3.6% rosavins is further provided.
- filters for example for smoking or vaporization equipment, containing, impregnated or coated with, a mixture of the purified alkaloids and dried spent Rhodiola plant matter produced according to the method of extraction.
- Fig. 1 illustrates constituent phenolic compounds known to be found in equilibrium in R. Rosea.
- Fig. 2 illustrates a chromatogram of R. rosea extract at a UV wavelength of 205 nm (A) and 254 nm (B) using the proposed method
- Fig. 3 illustrates a separation of the mixed compounds from raw R. Rosea. DETAILED DESCRIPTION
- An embodiment of the invention is a method of extracting a Rhodiola plant including the steps of harvesting and drying the plant; extracting the alkaloids from the plant in a solvent; filtering the solvent- Rhodiola plant mixture to remove the solvent and extracted alkaloids from a spent Rhodiola plant matter; drying the spent plant matter; purifying and separating the extracted alkaloids from the solvent; and mixing the purified alkaloids back into the dried spent plant matter.
- the Rhodiola plant is combined with a known solvent (the solvent may be determined upon the method of ‘separation’ chosen and the criteria of the equipment being used).
- the solvent may be determined upon the method of ‘separation’ chosen and the criteria of the equipment being used.
- the bulk of the desired phytochemicals soluble in the selected solvent are isolated away from bulk fibers, structural plant material and cell debris. Depleted waste materials such as fibers, structural plant components, and cell debris may be disposed of in chemical waste containers.
- phytochemicals such as cannabidiols (CBD)
- CBD cannabidiols
- other cannabis components could be added such as, for instance, but not limited to, cannabielsoin (CBE), cannabinol (CBN), cannabichromene (CBC), and cannabigerol (CBG), thus leading to different ultimate combinations.
- This mixture may be prepared in a simple base extract and processed by Soxhlet extraction or other industry accepted methodologies or systems.
- Soxhlet extraction the solvent is then removed, and the extract is subjected to acidification (H2SO4).
- An organic solvent such as hexane
- An ammonia solution to neutralize it and result in an alkaline solution.
- This alkaline solution may be further extracted with dichloromethane.
- solvent fractions can then be collected into a flask, filtered, and the solvent removed to yield a liquid containing only the desired alkaloids.
- Removal of the solvent from the desired alkaloids may be carried out by known processes, including, but not limited to, distillation, open-dish evaporation, reduced-pressure evaporation, rotary evaporation, vacuum, lyophilization, or a combination of methods thereof. For instance, removal of the solvent in one embodiment is by rotary evaporation.
- the solvent may be a known food grade solvent, including but not limited to ethanol, methanol, hydroalcohol, acetone, acetonitrile, hexane, heptane, hexane, chloroform, dichloromethane, water, and mixtures thereof.
- the solvent is ethanol.
- the amount of solvent added is about 1 :1 with the plant matter.
- Solvents are chosen based on equipment specifications and the relative covalency of the compounds. There are many covalent compounds which could be used in this method.
- the heating step has particular temperature and time parameters dictated by the equipment used. For instance, ethanol, which is used in one embodiment, evaporates very easily under low vacuum, and thus the equipment cycling parameters are chosen based on the need for evaporation of the ethanol solvent.
- Removal of the solvent can be, but is not limited to, a process selected from distillation, open-dish evaporation, reduced-pressure evaporation, rotary evaporation, vacuum, lyophilization, or a combination of methods thereof. In one embodiment, the solvent is removed by rotary evaporation which is efficient in removing the solvent.
- the remaining alkaloid extracts that were removed from the solvent are then subjected to the purification and separation techniques to isolate the target alkaloid molecules away from the myriad of other phytochemicals extracted by the solvent, which may not be desired.
- the purification and separation of the alkaloids in the method is carried out by passing the solvent and extracted alkaloids over or through a process selected from column chromatography comprising a reverse stationary phase, a normal stationary phase or combination thereof, ion-exchange chromatography, gel-permeation (molecular sieve) chromatography, affinity chromatography, paper chromatography, thin-layer chromatography, gas chromatography, dye-ligand chromatography, hydrophobic interaction chromatography, pseudoaffinity chromatography, and high-pressure liquid chromatography (HPLC).
- a particular purification and separation technique is dictated by the equipment design to use the modality.
- oxalates which are found in raw plant material of some herbaceous plants.
- Traditional and contemporary methods of preparation serve to reduce levels of potentially harmful oxalates.
- Known analyses have indicated levels of 3.6-5.1% oxalate in wild type plants, which falls within the median range for crop plants like spinach or kale. It has been previously speculated that physical crushing of the plant and the fermentation process reduce the potentially harmful effects of oxalic acid.
- free oxalic acid is likely to complex with cell wall-associated calcium salts and precipitate as calcium oxalate when plant material is crushed.
- Purification and separation techniques should enable maximum removal of oxalates as they should remain outside of the established absorption medium through these methods.
- the eluents containing the target alkaloids at higher yields are collected for further processing.
- the isolated alkaloid products are then washed, filtered and dried.
- the purified, concentrated products are re-combined with the dried spent plant matter to produce an optimized product, a “whole herb,” to take advantage of the target alkaloids potency while utilizing the heightened “entourage effect” of the many undescribed phytochemicals found in the dried spent plant matter.
- This mixture of the purified alkaloids combined with the dried spent plant matter can then be “sprinkled” on other herbal products (i.e., ginger, turmeric, holy basil, among other known products) or mixed with other phytochemicals, phytonutrients, or phytomaterials by the consumer, packed into capsules or tablets, or re-solubilized into a second solvent liquid for further formulation, medicinal or commercial uses including application on or in known delivery vehicles, such as vaporizing liquids, electronic liquids (e-liquids) for vaporization, medicinal compositions, kief, saturated or infused rolling papers, and filters for tobacco and vaporizing equipment, and internasal delivery systems such as a spray.
- delivery vehicles such as vaporizing liquids, electronic liquids (e-liquids) for vaporization, medicinal compositions, kief, saturated or infused rolling papers, and filters for tobacco and vaporizing equipment, and internasal delivery systems such as a spray.
- the method could also further include solubilizing the mixture of the purified alkaloids and the dried spent plant matter in a second solvent, such as, for instance an electronic vaporizer liquid (“e-liquid”) or in a second solvent before putting in an e-liquid.
- a second solvent such as, for instance an electronic vaporizer liquid (“e-liquid”) or in a second solvent before putting in an e-liquid.
- the second solvent could be a known food grade solvent, including but not limited to ethanol, methanol, hydroalcohol, acetone, acetonitrile, hexane, heptane, hexane, chloroform, dichloromethane, water, and mixtures thereof.
- the second solvent liquid may be the same or different from the solvent of the mixture of the plant before the purification and separation step of the method. In one embodiment of the method, the amount of second solvent liquid added is about 1 :1 of the mixture of the purified alkaloids and dried spent plant matter product.
- Either the plant and the solvent mixture during extraction or the final mixture of the purified alkaloids and the dried spent plant matter can be mixed with other herbal products, including ginger, turmeric, holy basil, and cannabidiols (CBD) from known cannabinoids.
- CBD cannabidiols
- CBD cannabidiols
- CBD cannabidiols
- a different cannabis component can be used in the mix such as, for instance, but not limited to, cannabielsoin (CBE), cannabinol (CBN), cannabichromene (CBC), cannabigerol (CBG) and mixtures thereof.
- the cannabidiol source can be selected from, but is not limited to, hemp plant, crude hemp oil, kief, nabiximol, epidiolex, and combinations thereof, and preferably is crude hemp oil.
- Cannabinoids can be defined as any extract, isolate, or derivative of the Cannabaceae genus of botanicals, comprising the C. Sativa, C. Indica, and C.
- the cannabidiol (CBD) sources can include but are not limited to hemp plant, crude hemp oil, nabiximol, epidiolex, and combinations thereof to provide the cannabidiols (CBD) for combination with the mixtures in the present methods.
- CBD cannabidiol
- the cannabidiol (CBD) is crude hemp oil.
- a combination of cannabidiols is utilized in the methods presented herein.
- Figure 1 Provided in Figure 1 is an illustration of phenolic compounds available in R. Rosea.
- salidrosides, rosavins, tyrosol, rosarin, rosin, and cinnamyl alcohol are isolated, concentrated, and re-suspended with the raw whole Rhodiola plant matter of the method in order to provide a full-Spectrum extract with concentrated, stabilized target molecules.
- Figure 2 shows a Chromatogram of R. rosea extract at a UV wavelength of 205 nm (A) and 254 nm (B) using the proposed method, kept at 40C, mobile phases: A- H20 and B- CH3CN in the following gradients: 0 to 6 min, 6 to 17% B; 6 to 7 min, 17 to 19.7% B, 7 to 9 min, kept at 19.7% B,9 to 10 min, 19.7 to 100% B, flow rate: 1.0 mL/min, injection volume: 1 pL).
- UV detection A: 205 nm, B: 254 nm.
- the primary target molecules are Salidrosides at a minimum concentration of 5% and Rosaivins at a minimum concentration of 3%, in addition to a minimum of doubling the concentration of other target molecules such as tyrosol, rosarin, rosin, and cinnamyl alcohol, which is then dried recombined with bulk raw extract.
- Target molecules are then resuspended in raw crude extract at a 1 :1 concentration with the target molecules. Unexpectedly, this does not increase the concentration of the raw crude extract, but rather, it spikes or unexpectedly selects for certain target molecules within the combination while at the same time isolates additional molecules in the extract as well which were not expected or potentially were unknown. This provides the benefit of the variety of molecules both known and unknown within the crude extract as well as the benefit of including the added concentrated, purified target molecules.
- Figure 3 shows the separation of the mixed compounds from raw R. rosea, including salidroside 1 , tyrosol 2, rosarin 3, rosavin 4, rosinand 5, and rosiridin 6. The same conditions as in Fig. 2 are used.
- Rhodiola is an effective extraction process for retrieving alkaloids contained in the Rhodiola (R Rosea) plant which possess significant bioactivity include: tyrosol, rosarin, rosin, cinnamyl alcohol, salidrosides, and rosavins.
- the extraction process sand methodologies provides consistent results, through many trials.
- compositions for treatment of psychological disorders ranging from depression to anxiety.
- the resulting compositional output of the present method may be used to treat disorders in the form of a sleep aid, pain relief, performance enhancer, premenstrual syndrome, and eating disorders.
Landscapes
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Agronomy & Crop Science (AREA)
- Botany (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Toxicology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
A method of extracting a Rhodiola plant comprising the steps of harvesting and drying the plant; extracting the alkaloids from the plant in a solvent; filtering the solvent- Rhodiola plant mixture to remove the solvent and extracted alkaloids from a spent plant matter; drying the spent plant matter; purifying and separating the extracted alkaloids from the solvent; and mixing the purified alkaloids back into the dried spent plant matter. Also, products of the method include vaporizing liquids, medicinal compositions, kief compositions, rolling papers, and filters for tobacco and vaporizing equipment comprising the mixture of the purified alkaloids and the dried spent plant matter produced according to the method. Further disclosed is a Rhodiola plant having approximately 1.3-8.57% total phenolic compounds containing 1-3.5% salidrosides and 0.03 - 3.6% Rosavins
Description
HIGH YIELD EXTRACTION METHOD FOR AND PRODUCTS OF RHODIOLA PLANTS
CROSS-REFERENCE TO RELATED APPLICATIONS
[0001] The present application is a Continuation-in-Part of U.S. application Ser. No. 17/093,937, filed November 10, 2020, which is incorporated herein by reference in its entirety.
FIELD OF THE INVENTION
[0002] The present invention relates to methods of high yield extraction of herbaceous plant matter. More particularly, the present invention relates to methods of high yield extraction of Rhodiola Rosea plant species, and products thereof, for medicinal and commercial use.
BACKGROUND
[0003] The historically therapeutic plant (genus) Rhodiola, an herbaceous plant, is indigenous to various parts of Northern China and Russia. There are at least three species of Rhodiola, of which, consuming of Rhodiola Rosea is preferred.
[0004] Crude plant extracts or plant material traditionally consumed by ingestion contains many compounds, such as secondary metabolites, which may affect many targets in the body simultaneously. These complex mixtures of phytochemicals may have numerous, synergistic effects in the body and “minor” metabolites may likely affect targets that have an equilibrizing effect that can, for example, mitigate side effects as compared to a synthetic pure pharmaceutical. The overall effect may be more desirable and more potent than that of only one compound alone.
[0005] Known cultivars of the cannabis plant produce hundreds of compounds with therapeutic potential and capacity to induce synergic responses when made to be combined. This heightened effect is referred to as the “entourage effect”. Often the
entourage effect of the supportive but undescribed molecules in a whole plant extract may potentiate the target molecules, yielding a more desirable result. For instance, one study tested the anti-tumor efficacy of the botanical drug preparation (whole plant extract) versus pure tetrahydrocannabinol (THC) against breast cancer <URL: httDs://www.sciencedirect.com/science/article/abs/oii/S0006295218302387> . The results provide that while pure THC acted by activating cannabinoid CB2 receptors and generating reactive oxygen species, the whole plant extract modulated different targets and mechanisms of action. These, and other similar experimental results suggest that standardized cannabis drug preparations, rather than pure cannabinoids, could be considered as part of the therapeutic armamentarium to manage various diseases and in this particular study, breast cancer.
[0006] However, processes for extraction of the alkaloids related to how they influence the entourage effect are under advanced and not available for the scientific and global community.
[0007] The alkaloids contained in Rhodiola (e.g., Rhodiola Rosea) are believed to possess significant bioactivity and psychoactivity and at least include salidrosides, rosavins, tyrosol, roasarin, rosin, and cinnamyl alcohol. A consumable concentration of 5% salidrosides and 3% rosavins is considered to be optimized for action as an agonist on the cannabinoid receptors for use with cannabis (and other herbs).
[0008] Plant hybridization of plant species, such as those in the Rhodiola genus, may occur naturally and through cultivation. Hybridized medicinal or non-medicinal plants provide many benefits, including phytochemical and phytonutrient enriched properties and increased yields of certain alkaloids that have yet to be further researched and discovered. Such plants may be desirable in embodiments of the present extraction method for the unique outputs and thus compositions achievable. [0009] Two receptors, CB1 and CB2, of the endocannabinoid system have been identified so far, with consensus being that there very well could be more yet to be discovered. CB1 and CB2 receptors are both G-protein coupled receptors.
Endocannabinoids act as retrograde signaling messengers that stimulate presynaptic CB1 receptors on neurons in the brain. This stimulation results in regulation of ion
channel activities, inhibition of adenylate cyclase activity and activation of the mitogen- activated protein kinase cascade.
[0010] CB1 receptors are the most abundant receptors in the mammalian brain, and also have been detected in other peripheral tissues and cells such as testis, eye, urinary bladder, ileum and adipocytes, though in lower concentrations than in the brain. CB1 receptors are found in brain areas related to the control of anxiety and emotional perception. In rats, CB1 receptors have been found with 5-HT transporters in the amygdale, suggesting that they mediate 5-HT release therefore possibly a target for the treatment of disorders related to mood, anxiety and cognition.
[0011] Rhodiola species (i.e. Rhodiola Rosea) have been shown to display potent CB1 receptor binding. The mood enhancing and stimulant properties of the whole plant extract of Rhodiola Rosea has been traditionally utilized for therapeutic purposes in Russia, Scandinavia, and China . In addition to these effects, preparations of R. Rosea have shown it can improve cognitive function and memory. These effects have been confirmed by proving serotonin-uptake inhibition activity with unfermented alkaloid extracts proving to possess a higher activity to bind CB1 receptor compared to that of fermented alkaloid extracts.
[0012] Despite the vast forward progress in herbal medicinal research, the properties (specific phytonutrients, phytomaterials, and certain phytochemicals) and effects of the alkaloids extracted from plant species of R. Rosea and current extraction processes to advance these properties and effects regarding how they affect the biochemical reactions of the endocannabinoid system remain in need of further development.
BRIEF SUMMARY OF THE INVENTION
[0013] A method of extracting a Rhodiola plant which includes the steps of harvesting and drying the Rhodiola plant; extracting the alkaloids from the Rhodiola plant in a solvent; filtering the solvent-Rhodiola plant mixture to remove the solvent and extracted alkaloids from a spent Rhodiola plant matter; drying the spent Rhodiola plant matter; purifying and separating the extracted alkaloids from the solvent; and mixing the purified alkaloids back into the dried spent Rhodiola plant matter.
[0014] Also provided is a vaporizing liquid having a mixture of the purified alkaloids and the dried spent Rhodiola plant matter produced according to the method of extraction. Further provided is a vaporizing liquid wherein the extraction method further has a step of solubilizing in a second solvent.
[0015] Further provided is a medicinal composition having a mixture of the purified alkaloids and dried spent Rhodiola plant matter produced according to the method of extraction.
[0016] Moreover, a kief composition is provided having a mixture of the purified alkaloids and dried spent Rhodiola plant matter produced according to the method of extraction.
[0017] Even further provided are papers for combustion, for instance in smoking, impregnated or coated with a mixture of the purified alkaloids and dried spent Rhodiola plant matter produced according to the method of extraction.
[0018] A Rhodiola plant having a total phenolic compound content of 1 .3-8.57% containing 1-3.5% salidrosides and 0.03-3.6% rosavins is further provided.
[0019] Also provided are filters, for example for smoking or vaporization equipment, containing, impregnated or coated with, a mixture of the purified alkaloids and dried spent Rhodiola plant matter produced according to the method of extraction.
[0020] Numerous other features and advantages of the present invention will be readily apparent to those of ordinary skill in the art upon reading of the following detailed description of presently preferred, but nonetheless illustrative, embodiments of the present invention when taken in conjunction with the accompanying figures. In this respect, before explaining embodiments of the invention in detail, it is to be understood that the invention is not limited in its application to the details of construction and to the arrangements of the components set forth in the following description or illustrated in the figures. The invention is capable of other embodiments and of being practiced and carried out in various ways. Also, it is to be understood that the phraseology and terminology employed herein are for the purpose of description and should not be regarded as limiting.
[0021] Before undertaking the detailed description of the invention below, it may be advantageous to set forth definitions of certain words and phrases used throughout this
patent document. Throughout this specification, unless the context requires otherwise, the word "comprise" or variations such as "comprises" or "comprising" or the term "includes" or variations, thereof, or the term "having" or variations, thereof will be understood to imply the inclusion of a stated element or integer or group of elements or integers but not the exclusion of any other element or integer or group of elements or integers. Furthermore, a person skilled in the art of reading claimed inventions should understand that "a" and "an" each generally denotes "at least one," but does not exclude a plurality unless the contextual use dictates otherwise. And that the term "or" denotes "at least one of the items," but does not exclude a plurality of items of the list. [0022] Those skilled in the art will appreciate that the invention described herein is susceptible to variations and modifications other than those specifically described. It is to be understood that the invention includes all such variations and modification which fall within its spirit and scope.
BRIEF DESCRIPTION OF THE FIGURES (NON-LIMITING EMBODIMENTS OF THE DISCLOSURE)
[0023] The invention will be better understood and aspects other than those set forth above will become apparent when consideration is given to the following description thereof. Such description makes reference to the annexed figures, wherein:
[0024] Fig. 1 illustrates constituent phenolic compounds known to be found in equilibrium in R. Rosea.
[0025] Fig. 2 illustrates a chromatogram of R. rosea extract at a UV wavelength of 205 nm (A) and 254 nm (B) using the proposed method
[0026] Fig. 3 illustrates a separation of the mixed compounds from raw R. Rosea. DETAILED DESCRIPTION
[0027] Hereinafter, methods of high yield extraction of plant matter of a Rhodiola Rosea plant species and products thereof for medicinal and commercial use have been described.
[0028] An embodiment of the invention is a method of extracting a Rhodiola plant including the steps of harvesting and drying the plant; extracting the alkaloids from the plant in a solvent; filtering the solvent- Rhodiola plant mixture to remove the solvent and
extracted alkaloids from a spent Rhodiola plant matter; drying the spent plant matter; purifying and separating the extracted alkaloids from the solvent; and mixing the purified alkaloids back into the dried spent plant matter.
[0029] Following the completion of the harvesting and drying of the Rhodiola plant, the Rhodiola plant is combined with a known solvent (the solvent may be determined upon the method of ‘separation’ chosen and the criteria of the equipment being used). During this step in the process, the bulk of the desired phytochemicals soluble in the selected solvent are isolated away from bulk fibers, structural plant material and cell debris. Depleted waste materials such as fibers, structural plant components, and cell debris may be disposed of in chemical waste containers.
[0030] In an alternate embodiment of the invention, other phytochemicals, phytonutrients, or phytomaterials such as cannabidiols (CBD) may be added to the plant and the solvent during this extraction step and in another embodiment, could be mixed at the end of the process. Again, in other embodiments, other cannabis components could be added such as, for instance, but not limited to, cannabielsoin (CBE), cannabinol (CBN), cannabichromene (CBC), and cannabigerol (CBG), thus leading to different ultimate combinations.
[0031] This mixture may be prepared in a simple base extract and processed by Soxhlet extraction or other industry accepted methodologies or systems. In the example of using Soxhlet extraction, the solvent is then removed, and the extract is subjected to acidification (H2SO4). An organic solvent (such as hexane) is used to wash the acidic solvent solution and the organic phase discarded, followed by adding an ammonia solution to neutralize it and result in an alkaline solution. This alkaline solution may be further extracted with dichloromethane.
[0032] These solvent fractions can then be collected into a flask, filtered, and the solvent removed to yield a liquid containing only the desired alkaloids. Removal of the solvent from the desired alkaloids may be carried out by known processes, including, but not limited to, distillation, open-dish evaporation, reduced-pressure evaporation, rotary evaporation, vacuum, lyophilization, or a combination of methods thereof. For instance, removal of the solvent in one embodiment is by rotary evaporation.
[0033] The solvent may be a known food grade solvent, including but not limited to ethanol, methanol, hydroalcohol, acetone, acetonitrile, hexane, heptane, hexane, chloroform, dichloromethane, water, and mixtures thereof. For instance, in one embodiment, the solvent is ethanol. In an embodiment of the method, the amount of solvent added is about 1 :1 with the plant matter.
[0034] Solvents are chosen based on equipment specifications and the relative covalency of the compounds. There are many covalent compounds which could be used in this method. The heating step has particular temperature and time parameters dictated by the equipment used. For instance, ethanol, which is used in one embodiment, evaporates very easily under low vacuum, and thus the equipment cycling parameters are chosen based on the need for evaporation of the ethanol solvent. [0035] Removal of the solvent can be, but is not limited to, a process selected from distillation, open-dish evaporation, reduced-pressure evaporation, rotary evaporation, vacuum, lyophilization, or a combination of methods thereof. In one embodiment, the solvent is removed by rotary evaporation which is efficient in removing the solvent. [0036] After filtration, the remaining alkaloid extracts that were removed from the solvent are then subjected to the purification and separation techniques to isolate the target alkaloid molecules away from the myriad of other phytochemicals extracted by the solvent, which may not be desired. The purification and separation of the alkaloids in the method is carried out by passing the solvent and extracted alkaloids over or through a process selected from column chromatography comprising a reverse stationary phase, a normal stationary phase or combination thereof, ion-exchange chromatography, gel-permeation (molecular sieve) chromatography, affinity chromatography, paper chromatography, thin-layer chromatography, gas chromatography, dye-ligand chromatography, hydrophobic interaction chromatography, pseudoaffinity chromatography, and high-pressure liquid chromatography (HPLC). Use of a particular purification and separation technique is dictated by the equipment design to use the modality.
[0037] An example of an undesired product of herbal plant extraction are oxalates, which are found in raw plant material of some herbaceous plants. Traditional and contemporary methods of preparation serve to reduce levels of potentially harmful
oxalates. Known analyses have indicated levels of 3.6-5.1% oxalate in wild type plants, which falls within the median range for crop plants like spinach or kale. It has been previously speculated that physical crushing of the plant and the fermentation process reduce the potentially harmful effects of oxalic acid. In particular, free oxalic acid is likely to complex with cell wall-associated calcium salts and precipitate as calcium oxalate when plant material is crushed. Purification and separation techniques (such as flash chromatography) should enable maximum removal of oxalates as they should remain outside of the established absorption medium through these methods. The eluents containing the target alkaloids at higher yields are collected for further processing. [0038] Once the active target molecules are purified to an acceptable extent and concentrated, the isolated alkaloid products are then washed, filtered and dried. The purified, concentrated products (target alkaloids or optionally added phytochemicals) are re-combined with the dried spent plant matter to produce an optimized product, a “whole herb,” to take advantage of the target alkaloids potency while utilizing the heightened “entourage effect” of the many undescribed phytochemicals found in the dried spent plant matter.
[0039] This mixture of the purified alkaloids combined with the dried spent plant matter can then be “sprinkled” on other herbal products (i.e., ginger, turmeric, holy basil, among other known products) or mixed with other phytochemicals, phytonutrients, or phytomaterials by the consumer, packed into capsules or tablets, or re-solubilized into a second solvent liquid for further formulation, medicinal or commercial uses including application on or in known delivery vehicles, such as vaporizing liquids, electronic liquids (e-liquids) for vaporization, medicinal compositions, kief, saturated or infused rolling papers, and filters for tobacco and vaporizing equipment, and internasal delivery systems such as a spray.
[0040] The method could also further include solubilizing the mixture of the purified alkaloids and the dried spent plant matter in a second solvent, such as, for instance an electronic vaporizer liquid (“e-liquid”) or in a second solvent before putting in an e-liquid. The second solvent could be a known food grade solvent, including but not limited to ethanol, methanol, hydroalcohol, acetone, acetonitrile, hexane, heptane, hexane, chloroform, dichloromethane, water, and mixtures thereof.
[0041] The second solvent liquid may be the same or different from the solvent of the mixture of the plant before the purification and separation step of the method. In one embodiment of the method, the amount of second solvent liquid added is about 1 :1 of the mixture of the purified alkaloids and dried spent plant matter product.
[0042] Either the plant and the solvent mixture during extraction or the final mixture of the purified alkaloids and the dried spent plant matter can be mixed with other herbal products, including ginger, turmeric, holy basil, and cannabidiols (CBD) from known cannabinoids.
[0043] In an embodiment of this invention, cannabidiols (CBD) could be added to the plant and the solvent during extraction, and in another embodiment, CBD can be added at the end of the process after all products are dried/mixed together. In yet another embodiment, a different cannabis component can be used in the mix such as, for instance, but not limited to, cannabielsoin (CBE), cannabinol (CBN), cannabichromene (CBC), cannabigerol (CBG) and mixtures thereof. The cannabidiol source can be selected from, but is not limited to, hemp plant, crude hemp oil, kief, nabiximol, epidiolex, and combinations thereof, and preferably is crude hemp oil.
[0044] Cannabinoids can be defined as any extract, isolate, or derivative of the Cannabaceae genus of botanicals, comprising the C. Sativa, C. Indica, and C.
Ruderalis families, or any combination thereof, produced by - or as part of - a synthetic transformative process involving any other combination of cannabinoids or their derivatives. This starting material can be obtained from any commercially available sources, or synthesized in situ, at a time prior to inception of the methods described herein. The cannabidiol (CBD) sources can include but are not limited to hemp plant, crude hemp oil, nabiximol, epidiolex, and combinations thereof to provide the cannabidiols (CBD) for combination with the mixtures in the present methods. In one embodiment of the cannabidiol (CBD) is crude hemp oil. In an alternative embodiment, a combination of cannabidiols is utilized in the methods presented herein.
[0045] Provided in Figure 1 is an illustration of phenolic compounds available in R. Rosea.
[0046] By the present method, salidrosides, rosavins, tyrosol, rosarin, rosin, and cinnamyl alcohol are isolated, concentrated, and re-suspended with the raw whole
Rhodiola plant matter of the method in order to provide a full-Spectrum extract with concentrated, stabilized target molecules.
[0047] The process of separation and isolation of alkaloids from Rhodiola species via flash chromatography can be carried out after filtration. Referencing relevant alkaloid reference standards in order to properly identify the target molecules, a Biotage® Flash chromatography Isolera Single Channel system or Biotage Selekt® Flash Chromatography system utilizing a C18 reverse phase silica column and detected at a UV wavelength of 228 nm was used. Methanol and 1% acetic acid in water mixed over a 25-minute gradient program, passes through the C18 column, separating out the target alkaloids by detectable peaks on the chromatogram. This is a typical HPLC chromatogram of a methanol extract and the retention times of major compounds purported to elute at 2.38, 3.15, 4.89 and 7.84 and a flow rate of 1ml/min.
[0048] Following the separation of components by flash chromatography, collected eluents are then filtered and processed again through the Flash Chromatography unit (Biotage Isolera or Selekt chromatography system), utilizing resins with different characteristics such as charge or hydrophobicity yielding pure target products of salidrosides, rosavins, tyrosol, rosarin, rosin, and cinnamyl alcohol (as well as others). These concentrated molecules were then re-suspended into the whole herb extract to produce the desired product at multiple units of concentration.
[0049] At the extraction phase we expect a concentration of approximately 1 .3- 8.57% total phenolic compounds containing 1-3.5% salidrosides and 0.03 - 3.6% Rosavins. After the chromatography steps our primary target molecule salidrosides will have a minimum concentration of 5% and rosavins 3%. Other non-primary target molecules including tyrosol, rosarin, rosin, and cinnamyl alcohol, has a minimum concentration range from 2:1 , 5:1, 8:1 , up to 10:1 respectively.
[0050] The extraction process consistently demonstrates higher yields. For instance, the experiment was run four times four and run through chromatography as discussed herein. The same conditions were used, and the below table provides the output of target molecules detected in the elution and isolation step for each of the four runs.
[0051] Figure 2 shows a Chromatogram of R. rosea extract at a UV wavelength of 205 nm (A) and 254 nm (B) using the proposed method, kept at 40C, mobile phases: A-
H20 and B- CH3CN in the following gradients: 0 to 6 min, 6 to 17% B; 6 to 7 min, 17 to 19.7% B, 7 to 9 min, kept at 19.7% B,9 to 10 min, 19.7 to 100% B, flow rate: 1.0 mL/min, injection volume: 1 pL). UV detection: A: 205 nm, B: 254 nm.
[0052] The primary target molecules are Salidrosides at a minimum concentration of 5% and Rosaivins at a minimum concentration of 3%, in addition to a minimum of doubling the concentration of other target molecules such as tyrosol, rosarin, rosin, and cinnamyl alcohol, which is then dried recombined with bulk raw extract.
[0053] Target molecules are then resuspended in raw crude extract at a 1 :1 concentration with the target molecules. Unexpectedly, this does not increase the concentration of the raw crude extract, but rather, it spikes or unexpectedly selects for certain target molecules within the combination while at the same time isolates additional molecules in the extract as well which were not expected or potentially were unknown. This provides the benefit of the variety of molecules both known and unknown within the crude extract as well as the benefit of including the added concentrated, purified target molecules.
[0054] Figure 3 shows the separation of the mixed compounds from raw R. rosea, including salidroside 1 , tyrosol 2, rosarin 3, rosavin 4, rosinand 5, and rosiridin 6. The same conditions as in Fig. 2 are used.
[0055] Experimental results also show that the bulk extraction of Rhodiola is an effective extraction process for retrieving alkaloids contained in the Rhodiola (R Rosea) plant which possess significant bioactivity include: tyrosol, rosarin, rosin, cinnamyl alcohol, salidrosides, and rosavins. As such the extraction process sand methodologies provides consistent results, through many trials.
[0056] Providing the concentrated, stabilized target molecules at an effective concentration of 2:1 , 5:1, 8:1 , 10:1 or more in order to achieve desired biological activities unexpectedly and advantageously produced the unknown heightened “entourage effect” of countless other phytonutrients in the plant that were not extracted, and thus provides a "whole-herb" extract delivery for medicinal and commercial use. This heightened “entourage effect” activity through the extraction method of the R. Rosea plant also provides unrealized insight in relation to how phytochemicals and cannabinoids are metabolized by the body through the endocannabinoid system. As a
result of the higher yields of the alkaloids in the Rhodiola plant and the heightened entourage effect, further advancements with mixtures of these alkaloid products with additional phytonutrients, phytomaterials, and phytochemicals such as cannabinoids themselves can be envisioned for enhanced synergistic effects. Medicinal uses and commercial uses are both envisioned.
[0057] Some medicinal uses may include, but are not limited to, compositions for treatment of psychological disorders ranging from depression to anxiety. The resulting compositional output of the present method may be used to treat disorders in the form of a sleep aid, pain relief, performance enhancer, premenstrual syndrome, and eating disorders.
[0058] Various delivery vehicles can be used, as discussed above, and the choice of the same will depend on various factors such as, but not limited to, the desired result or ease of manipulation or even the speed of delivery or efficacy, and the concentration of the final composition of the present method could be dictated by the desired effect, the subject, what is being treated, a combination of any of the same and other factors. [0059] While certain embodiments of the methods herein have been described in detail with reference to the accompanying figures, it should be apparent that modifications and variations thereto are possible, all of which fall within the true spirit and scope of the invention. The invention also includes all of the steps, features, compositions and compounds referred to or indicated in this specification, individually or collectively, and any and all combinations of any two or more of said steps or features. [0060] As such, those skilled in the art will appreciate that the conception, upon which this disclosure is based may readily be utilized as a basis for other compositions, formulations, methods and systems for carrying out the several purposes of the present invention. It is important, therefore, that the claims be regarded as including such equivalent constructions insofar as they do not depart from the spirit and scope of the present invention.
[0061] Further, the purpose of the foregoing Abstract is to enable the U.S. Patent and Trademark Office and the public generally, and especially the scientists, engineers and practitioners in the art who are not familiar with patent or legal terms or phraseology, to determine quickly from a cursory inspection the nature and essence of
the technical disclosure of the application. The Abstract is neither intended to define the invention of the application, which is measured by the claims, nor is it intended to be limiting as to the scope of the invention in any way.
[0062] These together with other aspects of the invention, along with the various features of novelty that characterize the invention, are pointed out with particularity in the claims annexed to and forming a part of this disclosure. For a better understanding of the invention, its operating advantages and the specific aspects attained by its uses, reference should be had to the accompanying figures and description matter in which there are illustrated preferred embodiments of the invention.
[0063] Therefore, the foregoing is considered as illustrative only of the principles of the invention. Further, since numerous modifications and changes will readily occur to those skilled in the art, it is not desired to limit the invention to the exact construction and operation shown and described, and accordingly, all suitable modifications and equivalents may be resorted to, falling within the scope of the invention.
Claims
1 . A method of extracting a Rhodiola plant comprising the steps of: harvesting and drying the Rhodiola plant; extracting the alkaloids from the Rhodiola plant in a solvent; filtering the solvent-Rhodiola plant mixture to remove the solvent and extracted alkaloids from a spent Rhodiola plant matter; drying the spent Rhodiola plant matter; purifying and separating the extracted alkaloids from the solvent; and mixing the purified alkaloids back into the dried spent Rhodiola plant matter.
2. The method according to claim 1, wherein the Rhodiola plant has a total phenolic compound content of 1 .3-8.57% containing 1-3.5% salidrosides and 0.03 - 3.6% Rosavins.
3. The method according to claim 1 , wherein the solvent is selected from the group consisting of ethanol, methanol, hydroalcohol, acetone, acetonitrile, hexane, heptane, hexane, chloroform, dichloromethane, water, and mixtures thereof.
4. The method according to claim 3, wherein the solvent is ethanol.
5. The method according to claim 1 , wherein the removal of the solvent is by a process selected from the group consisting of distillation, open-dish evaporation,
reduced-pressure evaporation, rotary evaporation, vacuum, lyophilization, or a combination of methods thereof.
6. The method according to claim 5, wherein the removal of the solvent is by rotary evaporation.
7. The method according to claim 1 , wherein the purification and separation of the phenolic compounds is carried out by passing the solvent and extracted alkaloids over or through a process selected from the group consisting of column chromatography comprising a reverse stationary phase, a normal stationary phase or combination thereof, ion-exchange chromatography, gel-permeation (molecular sieve) chromatography, affinity chromatography, paper chromatography, thin-layer chromatography, gas chromatography, dye-ligand chromatography, hydrophobic interaction chromatography, pseudoaffinity chromatography, and high-pressure liquid chromatography (HPLC).
8. The method according to claim 1 , wherein the method further comprises adding cannabidiols (CBD) to the Rhodiola plant and the solvent during extraction.
9. The method according to claim 8, wherein the cannabidiols source is selected from the group consisting of hemp plant, crude hemp oil, kief, nabiximol, epidiolex, and combinations thereof.
10. The method according to claim 9, wherein the cannabidiols source is crude hemp oil.
11 . The method according to claim 1 , wherein the method further comprises adding cannabidiols (CBD) to the mixture of the purified alkaloids and the dried spent Rhodiola plant matter.
12. The method according to claim 11 , wherein the cannabidiols source is selected from the group consisting of hemp plant, crude hemp oil, kief, nabiximol, epidiolex, and combinations thereof.
13. The method according to claim 12, wherein the cannabidiol source is crude hemp oil.
14. The method according to claim 1 , wherein the method further comprises solubilizing the mixture of the purified alkaloids and the dried spent Rhodiola plant matter in a second solvent.
15. The method according to claim 14, wherein the second solvent is selected from the group consisting of ethanol, methanol, hydroalcohol, acetone, acetonitrile, hexane, heptane, hexane, chloroform, dichloromethane, water, and mixtures thereof.
16. The method of claim 14, further comprising the step of mixing the purified phenolic compounds and the dried spent Rhodiola plant matter into a vaporizing liquid.
17. The method of claim 1 , further comprising the step of preparing a medicinal composition comprising the mixture of the purified phenolic compounds and the dried spent Rhodiola plant matter.
18. The method of claim 1 , further comprising the step of preparing a kief composition comprising the mixture of the purified phenolic compounds and the dried spent Rhodiola plant matter.
19. The method of claim 1 , further comprising the step of preparing at least one rolling paper for combustion comprising the mixture of the purified phenolic compounds and the dried spent Rhodiola plant matter.
20. The method of claim 1 , further comprising the step of preparing at least one smoking filter comprising the mixture of the purified phenolic compounds and the dried spent Rhodiola plant matter.
21. A vaporizing liquid comprising phenolic compounds produced and purified by the method of claim 16.
22. A medicinal compound comprising a mixture of phenolic compounds produced and purified by the method of claim 17.
23. A kief composition comprising a mixture of phenolic compounds produced and purified by the method of claim 18.
24. Paper for combustion comprising a mixture of the phenolic compounds produced and purified by the method of claim 19.
25. A smoking filter comprising the mixture of purified phenolic compounds produced and purified by the method of claim 20.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US2022/014357 WO2023146536A1 (en) | 2022-01-28 | 2022-01-28 | High yield extraction method for and products of rhodiola plants |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US2022/014357 WO2023146536A1 (en) | 2022-01-28 | 2022-01-28 | High yield extraction method for and products of rhodiola plants |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2023146536A1 true WO2023146536A1 (en) | 2023-08-03 |
Family
ID=87472164
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2022/014357 WO2023146536A1 (en) | 2022-01-28 | 2022-01-28 | High yield extraction method for and products of rhodiola plants |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2023146536A1 (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060079495A1 (en) * | 1999-08-04 | 2006-04-13 | Kenneth Blum | Diagnosis and treatment system for "reward deficiency syndrome" (RDS) and related behaviors |
WO2013020368A1 (en) * | 2011-08-08 | 2013-02-14 | The Hong Kong University Of Science And Technology | Rhodiola rosea extracts and isolated compounds and uses thereof for treating neurodegenerative diseases |
US20160310684A1 (en) * | 2014-02-11 | 2016-10-27 | Timothy McCullough | Methods and delivery devices using herbal extracts |
US11154087B2 (en) * | 2016-02-02 | 2021-10-26 | R.J. Reynolds Tobacco Company | Method for preparing flavorful compounds isolated from black liquor and products incorporating the flavorful compounds |
-
2022
- 2022-01-28 WO PCT/US2022/014357 patent/WO2023146536A1/en unknown
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060079495A1 (en) * | 1999-08-04 | 2006-04-13 | Kenneth Blum | Diagnosis and treatment system for "reward deficiency syndrome" (RDS) and related behaviors |
WO2013020368A1 (en) * | 2011-08-08 | 2013-02-14 | The Hong Kong University Of Science And Technology | Rhodiola rosea extracts and isolated compounds and uses thereof for treating neurodegenerative diseases |
US20160310684A1 (en) * | 2014-02-11 | 2016-10-27 | Timothy McCullough | Methods and delivery devices using herbal extracts |
US11154087B2 (en) * | 2016-02-02 | 2021-10-26 | R.J. Reynolds Tobacco Company | Method for preparing flavorful compounds isolated from black liquor and products incorporating the flavorful compounds |
Non-Patent Citations (2)
Title |
---|
"Management of High Altitude Pathophysiology", vol. 5, 30 November 2017, ISBN: 978-0-12-814000-0, article SHARMA PRIYANKA, MISRA KSHIPRA: "Rhodiola sp.: The Herbal Remedy for High-Altitude Problems", pages: 81 - 92, XP009548584, DOI: 10.1016/B978-0-12-813999-8.00005-7 * |
JAMIOŁ MONIKA, WAWRZYKOWSKI JACEK, DEC MARTA, WILK AGATA, CZELEJ MICHAŁ: "Comparison of Various Techniques for the Extraction, Analysis of Compounds and Determination of Antioxidant Activities of Rhodiola Spp . - A Review", FOOD REVIEWS INTERNATIONAL, TAYLOR & FRANCIS, PHILADELPHIA, USA, vol. 39, no. 1, 2 January 2023 (2023-01-02), Philadelphia, USA , pages 467 - 487, XP093083731, ISSN: 8755-9129, DOI: 10.1080/87559129.2021.1918147 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Grijó et al. | Supercritical extraction strategies using CO2 and ethanol to obtain cannabinoid compounds from Cannabis hybrid flowers | |
US11040295B2 (en) | Method and apparatus for extracting plant oils using ethanol water | |
EP2030626B1 (en) | Process for the preparation of plant extracts for treating skin disorders and enhancing healing of wounds | |
US6403126B1 (en) | Cannabinoid extraction method | |
Johnston et al. | Modulation of ionotropic GABA receptors by natural products of plant origin | |
WO2010137943A1 (en) | Composition comprising caffeoylshikimic acids, protocatechuic acid, hydroxytyrosol, hydroxybenzoic acid and their derivatives and method of preparation thereof | |
US11801279B2 (en) | High yield extraction method for and products of Corydalis plants | |
Erdoğan et al. | Hydrodistillation of Nigella sativa seed and analysis of Thymoquinone with HPLC and GC-MS | |
US11607436B2 (en) | High yield extraction method for and products of Kanna plants | |
CA3157816C (en) | High yield extraction method for and products of kanna plants | |
Li et al. | Efficient preparation of caffeoylquinic acids from the flowers of Artemisia anomala by supramolecular solvent/equilibrium solution extraction followed by re-extraction | |
US11793848B2 (en) | High yield extraction method for and products of Rhodiola plants | |
Qureshi et al. | Estimation of biologically active cannabinoids in Cannabis indica by gas chromatography-mass spectrometry (GC-MS) | |
WO2023146536A1 (en) | High yield extraction method for and products of rhodiola plants | |
WO2023146537A1 (en) | High yield extraction method for and products of corydalis plants | |
Hendrawati et al. | Characterization and properties of Gedi (Abelmoschus manihot L.) leaf extract with liquid chromatography mass spectrometry using quadrupole time-of-flight technology (LCMS-QToF) | |
Jack et al. | Phytochemical constituents of dichloromethane fraction and essential oil of Napoleonaea imperialis rind | |
Bogdanovic et al. | Application of Plant Essential Oils in Pharma and Aroma Industries | |
Alhourani et al. | Chemical composition of essential oil and screening of antiproliferative activity of Paronychia argentea Lam. aerial parts: an ethno-medicinal plant from Jordan | |
Abu-Shandi et al. | A Quick GC/MS Method correlated with LC/MS/MS for the Identification of Medicinal Natural Products in Convolvulus arvensis: An Injury Healing Plant. | |
JP2003221333A (en) | Agent for inhibiting hyaluronidase | |
Soumahoro et al. | Identification of compounds by HPLC-ESI-Q-TOF-MS/MS analysis of the dichloromethane fraction from the hydroalcoholic extract of Hyptis suaveolens leaves before extraction of the essential oil | |
Zainal et al. | Bioactivity-guided fractionation of potent anti-cancer properties from non-edible tissues of Theobroma cacao | |
Jainab et al. | Antioxidant study of isolated chemical constituents from methanol extract of the Clerodendrum phlomidis leaf | |
Rožanc et al. | Different Cannabis sativa Extraction Methods Result in Different Biological Activities against a Colon Cancer Cell Line and Healthy Colon Cells. Plants 2021, 10, 566 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 22924462 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |